BRIEF published on 07/16/2025 at 08:05, 1 year 1 month ago GeNeuro SA announces the liquidation of its French subsidiary Restructuring Liquidation GeNeuro Subsidiary Neurodegenerative
BRIEF published on 07/16/2025 at 08:05, 1 year 1 month ago GeNeuro SA annonce la liquidation de sa filiale française Liquidation Restructuration GeNeuro Filiale Neurodégénératif
PRESS RELEASE published on 07/16/2025 at 08:00, 1 year 1 month ago Inside Information / Other news releases GeNeuro SA announces the liquidation of its French subsidiary GeNeuro Innovation SAS, part of the restructuring process. Court appointed liquidator SELARL MJ-Synergie Liquidation Restructuring Process GeNeuro SA GeNeuro Innovation SAS SELARL MJ-Synergie
PRESS RELEASE published on 07/16/2025 at 08:00, 1 year 1 month ago Informations privilégiées / Autres communiqués GeNeuro SA annonce la liquidation de sa filiale GeNeuro Innovation SAS. Le Tribunal de Lyon a prononcé la décision le 15 juillet 2025. La société GeNeuro poursuit sa restructuration Biopharmaceutique Restructuration Liquidation Judiciaire GeNeuro Neurodégénératives
BRIEF published on 06/30/2025 at 19:42, 1 year 2 months ago GeNeuro's Shareholders Approve All Resolutions at Extraordinary General Meeting Shareholder Approval Restructuring Extraordinary General Meeting GeNeuro Asset Monetization
BRIEF published on 06/30/2025 at 19:42, 1 year 2 months ago Les actionnaires de GeNeuro approuvent toutes les résolutions lors de l'assemblée générale extraordinaire Assemblée Générale Extraordinaire Restructuration Approbation Des Actionnaires GeNeuro Monétisation Des Actifs
PRESS RELEASE published on 06/30/2025 at 19:37, 1 year 2 months ago Inside Information / Other news releases GeNeuro announces approval of all resolutions proposed at Extraordinary General Meeting with 69.1% share capital representation. Jesús Martin-Garcia named Executive Chairman Shareholders EGM Resolutions GeNeuro Jesús Martin-Garcia
PRESS RELEASE published on 06/30/2025 at 19:37, 1 year 2 months ago Informations privilégiées / Autres communiqués Les actionnaires de GeNeuro approuvent l’ensemble des résolutions proposées à l’Assemblée Générale Extraordinaire du 30 juin 2025. Jesús Martin-Garcia nommé Président Exécutif Assemblée Générale Extraordinaire Resolutions GeNeuro Neurodégénératives Jesús Martin-Garcia
BRIEF published on 06/12/2025 at 22:47, 1 year 2 months ago GeNeuro SA : Redressement judiciaire pour sa filiale française Restructuration Redressement Judiciaire GeNeuro SA Administrateur Judiciaire Filiale Française
BRIEF published on 06/12/2025 at 22:47, 1 year 2 months ago GeNeuro SA: Judicial recovery for its French subsidiary Restructuring GeNeuro SA Judicial Recovery French Subsidiary Judicial Administrator
Published on 09/12/2026 at 02:35, 11 hours 13 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 48 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 43 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 23 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 48 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 18 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 33 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 38 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 3 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 33 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
